These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

612 related articles for article (PubMed ID: 28355988)

  • 1. Direct oral anticoagulants: an alternative treatment for thrombotic antiphospholipid syndrome?
    Resseguier AS; Pereira B; Rieu V; Le Guenno G; Grobost V; Ruivard M
    Lupus; 2017 Oct; 26(12):1297-1303. PubMed ID: 28355988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of direct oral anticoagulants in 56 patients with antiphospholipid syndrome.
    Malec K; Góralczyk T; Undas A
    Thromb Res; 2017 Apr; 152():93-97. PubMed ID: 27989533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct Oral Anticoagulants Use in Antiphospholipid Syndrome: Are These Drugs an Effective and Safe Alternative to Warfarin? A Systematic Review of the Literature.
    Dufrost V; Risse J; Zuily S; Wahl D
    Curr Rheumatol Rep; 2016 Dec; 18(12):74. PubMed ID: 27812956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rethinking the use of direct oral anticoagulants for secondary thromboprophylaxis in patients with thrombotic antiphospholipid syndrome.
    Franco-Moreno A; Izquierdo-Martínez A; Ancos-Aracil C
    Drug Discov Ther; 2024 Sep; 18(4):213-219. PubMed ID: 39198152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct oral anticoagulants in antiphospholipid syndrome: a real life case series.
    Betancur JF; Bonilla-Abadía F; Hormaza AA; Jaramillo FJ; Cañas CA; Tobón GJ
    Lupus; 2016 May; 25(6):658-62. PubMed ID: 26743321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of direct oral anticoagulants in antiphospholipid syndrome.
    Cohen H; Efthymiou M; Isenberg DA
    J Thromb Haemost; 2018 Jun; 16(6):1028-1039. PubMed ID: 29624847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct oral anticoagulants versus vitamin K antagonists in antiphospholipid syndrome: A meta-analysis.
    Cerdà P; Becattini C; Iriarte A; Hernández JC; Corbella X; Riera-Mestre A
    Eur J Intern Med; 2020 Sep; 79():43-50. PubMed ID: 32482595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombotic events in patients with antiphospholipid syndrome treated with rivaroxaban: a series of eight cases.
    Signorelli F; Nogueira F; Domingues V; Mariz HA; Levy RA
    Clin Rheumatol; 2016 Mar; 35(3):801-5. PubMed ID: 26219490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of lupus anticoagulant and triple marker positivity as risk factors for rethrombosis in patients with primary antiphospholipid syndrome.
    Hernández-Molina G; Espericueta-Arriola G; Cabral AR
    Clin Exp Rheumatol; 2013; 31(3):382-8. PubMed ID: 23305633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiphospholipid syndrome and challenges with direct oral anticoagulants.
    Booth S; Burton K; Hunt B; Desborough M
    Br J Hosp Med (Lond); 2020 May; 81(5):1-11. PubMed ID: 32468937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing the efficacy and safety of direct oral anticoagulants versus Vitamin K antagonists in patients with antiphospholipid syndrome: a systematic review and meta-analysis.
    Wu X; Cao S; Yu B; He T
    Blood Coagul Fibrinolysis; 2022 Oct; 33(7):389-401. PubMed ID: 35867933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased risk of thrombosis in antiphospholipid syndrome patients treated with direct oral anticoagulants. Results from an international patient-level data meta-analysis.
    Dufrost V; Risse J; Reshetnyak T; Satybaldyeva M; Du Y; Yan XX; Salta S; Gerotziafas G; Jing ZC; Elalamy I; Wahl D; Zuily S
    Autoimmun Rev; 2018 Oct; 17(10):1011-1021. PubMed ID: 30103045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rivaroxaban in antiphospholipid syndrome (RAPS) protocol: a prospective, randomized controlled phase II/III clinical trial of rivaroxaban versus warfarin in patients with thrombotic antiphospholipid syndrome, with or without SLE.
    Cohen H; Doré CJ; Clawson S; Hunt BJ; Isenberg D; Khamashta M; Muirhead N;
    Lupus; 2015 Sep; 24(10):1087-94. PubMed ID: 25940537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rivaroxaban Versus Vitamin K Antagonist in Antiphospholipid Syndrome: A Randomized Noninferiority Trial.
    Ordi-Ros J; Sáez-Comet L; Pérez-Conesa M; Vidal X; Riera-Mestre A; Castro-Salomó A; Cuquet-Pedragosa J; Ortiz-Santamaria V; Mauri-Plana M; Solé C; Cortés-Hernández J
    Ann Intern Med; 2019 Nov; 171(10):685-694. PubMed ID: 31610549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cessation of oral anticoagulants in antiphospholipid syndrome.
    Comarmond C; Jego P; Veyssier-Belot C; Marie I; Mekinian A; Elmaleh-Sachs A; Leroux G; Saadoun D; Oziol E; Fraisse T; Hyvernat H; Thiercein-Legrand MF; Sarrot-Reynauld F; Ferreira-Maldent N; de Menthon M; Goujard C; Khau D; Nguen Y; Monnier S; Michon A; Castel B; Decaux O; Piette JC; Cacoub P
    Lupus; 2017 Oct; 26(12):1291-1296. PubMed ID: 28355985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of anti-domain 1 β2-glycoprotein I antibodies in antiphospholipid syndrome.
    Iwaniec T; Kaczor MP; Celińska-Löwenhoff M; Polański S; Musiał J
    Thromb Res; 2017 May; 153():90-94. PubMed ID: 28363116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct oral anticoagulants in antiphospholipid syndrome: Meta-analysis of randomized controlled trials.
    Dufrost V; Wahl D; Zuily S
    Autoimmun Rev; 2021 Jan; 20(1):102711. PubMed ID: 33197580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of risk factors for the development of thrombotic complications in antiphospholipid antibody positive lupus patients.
    Tarr T; Lakos G; Bhattoa HP; Shoenfeld Y; Szegedi G; Kiss E
    Lupus; 2007; 16(1):39-45. PubMed ID: 17283584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for ischemic antiphospholipid syndrome: A case-control study.
    Matus-Mayorga R; Barrera-Vargas A; Rull-Gabayet M; Aguirre-Aguilar E; Valdez-López M; Espinoza-Lira F; Ramos-Ventura C; Cano-Nigenda V; Barboza MA; Merayo-Chalico J; Arauz A
    Clin Neurol Neurosurg; 2021 Mar; 202():106492. PubMed ID: 33540176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of the antiphospholipid syndrome with direct oral anticoagulantsPosition statement of German societies.
    Bauersachs R; Langer F; Kalka C; Konstantinides S; Klamroth R; Oldenburg J; Schellong S; Scholz U; Stücker M; Lindhoff-Last E
    Vasa; 2019 Nov; 48(6):483-486. PubMed ID: 31621546
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 31.